2026-04-14T04:59:21Zhttps://recercat.cat/oai/request

oai:recercat.cat:10256/261412025-02-03T08:40:06Zcom_2072_452955com_2072_2054col_2072_452960

00925njm 22002777a 4500 dc Porta Balanyà, Rut author Blancafort Jorquera, Adriana author Casòliva, Gemma author Casas, Miquel author Dorca Ribugent, Joan author Buxó Pujolràs, Maria author Viñas, Gemma author Oliveras, Glòria author Puig i Miquel, Teresa author 2014-02-21 Objective Overexpression of fatty acid synthase (FASN), the enzyme involved in the de novo synthesis of fatty acids, has been reported in several human carcinomas, including breast cancer, and has been related to poor prognosis. Our aim was to analyze the association of FASN tumor tissue expression with clinicopathological and anthropometrical features in early-stage breast cancer patients. Methods We prospectively studied 53 women with early-stage breast cancer who were treated with surgical operation and postoperative chemotherapy. Results Menopause status and age were strongly associated with higher levels of FASN tumor expression (P < 0.005 and P = 0.038, respectively). Body mass index and pathological stage were also related to FASN tumor expression. Conclusions Our findings suggest that FASN could be a potential therapeutic target in postmenopausal breast cancer patients. However, further studies are needed http://hdl.handle.net/10256/26141 Àcids grassos Menopausa Fatty acids Menopause Mama -- Càncer -- Pacients Breast cancer -- Patients Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients